These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7813311)

  • 21. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
    Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
    Mookherjee S; Obeid A; Warner R; Anderson G; Eich R; Smulyan H
    Am J Cardiol; 1978 Dec; 42(6):987-92. PubMed ID: 727149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension.
    Castelain V; Chemla D; Humbert M; Sitbon O; Simonneau G; Lecarpentier Y; Hervé P
    Am J Respir Crit Care Med; 2002 Feb; 165(3):338-40. PubMed ID: 11818317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of prostacyclin on coronary hemodynamics at rest and in response to cold pressor testing in patients with angina pectoris.
    Ganz P; Gaspar J; Colucci WS; Barry WH; Mudge GH; Alexander RW
    Am J Cardiol; 1984 Jun; 53(11):1500-4. PubMed ID: 6375336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostacyclin infusion does not prevent ACTH-induced hypertension in sheep.
    Mason RT; Coghlan JP; Congiu M; Denton DA; Fei DT; Whitworth JA; Scoggins BA
    Prostaglandins Leukot Med; 1985 May; 18(2):261-9. PubMed ID: 2989937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise.
    Blumberg FC; Riegger GA; Pfeifer M
    Chest; 2002 May; 121(5):1566-71. PubMed ID: 12006445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2.
    Cuiper LL; Price PV; Christman BW
    J Appl Physiol (1985); 1996 Jan; 80(1):191-7. PubMed ID: 8847301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative studies of hemodynamics under prostacyclin and nifedipine in patients with Eisenmenger syndrome].
    Gildein HP; Wildberg A; Mocellin R
    Z Kardiol; 1995 Jan; 84(1):55-63. PubMed ID: 7863716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
    Krowka MJ; Frantz RP; McGoon MD; Severson C; Plevak DJ; Wiesner RH
    Hepatology; 1999 Sep; 30(3):641-8. PubMed ID: 10462369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension.
    Heerdt PM; Weiss CI
    Ann Thorac Surg; 1990 Mar; 49(3):463-5. PubMed ID: 2106846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodynamic changes induced by prostacyclin in man.
    Szczeklik J; Szczeklik A; Nizankowski R
    Br Heart J; 1980 Sep; 44(3):254-8. PubMed ID: 7000101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.
    Aguilar RV; Farber HW
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1846-50. PubMed ID: 11069824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension.
    Strange C; Bolster M; Mazur J; Taylor M; Gossage JR; Silver R
    Chest; 2000 Oct; 118(4):1077-82. PubMed ID: 11035680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
    Cheng D; Chen W; Jiang J
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
    J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of adenosine and nifedipine in pulmonary hypertension.
    Schrader BJ; Inbar S; Kaufmann L; Vestal RE; Rich S
    J Am Coll Cardiol; 1992 Apr; 19(5):1060-4. PubMed ID: 1552096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S; Schrader BJ; Kaufmann E; Vestal RE; Rich S
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACTH hypertension modifies the haemodynamic effects of prostacyclin infusions in sheep.
    Mason RT; Allen KJ; Coghlan JP; Denton DA; Fei DT; Graham WF; Scoggins BA; Stewart KW
    Clin Exp Pharmacol Physiol; 1980; 7(5):469-72. PubMed ID: 6256103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C; Bohn DJ; Freedom RM; Rabinovitch M
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.
    Hinderliter AL; Willis PW; Barst RJ; Rich S; Rubin LJ; Badesch DB; Groves BM; McGoon MD; Tapson VF; Bourge RC; Brundage BH; Koerner SK; Langleben D; Keller CA; Murali S; Uretsky BF; Koch G; Li S; Clayton LM; Jöbsis MM; Blackburn SD; Crow JW; Long WA
    Circulation; 1997 Mar; 95(6):1479-86. PubMed ID: 9118516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.